XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenues [Abstract]      
Net revenues $ 453,911 $ 414,051 $ 356,546
Operating costs:      
Salaries and related costs 259,228 237,067 198,495
Rent, supplies, contract labor and other 88,426 82,096 71,868
Provision for doubtful accounts 4,603 3,672 4,040
Closure costs (9) 599 131
Total operating costs 352,248 323,434 274,534
Gross Profit 101,663 90,617 82,012
Corporate office costs 41,349 35,889 32,479
Operating income 60,314 54,728 49,533
Gain on derecognition of debt 1,846 0 0
Interest and other income, net 93 88 93
Interest expense:      
Mandatorily redeemable non-controlling interests - change in redemption value 0 (12,894) (6,169)
Mandatorily redeemable non-controlling interests - earnings allocable 0 (6,055) (4,057)
Debt and other (2,042) (2,111) (1,252)
Total interest expense (2,042) (21,060) (11,478)
Income before taxes 60,211 33,756 38,148
Provision for income taxes 11,369 6,032 11,880
Net income 48,842 27,724 26,268
Less: net income attributable to non-controlling interests      
Non-controlling interests - permanent equity (5,536) (5,224) (5,717)
Redeemable non-controlling interests - temporary equity (8,433) (244) 0
Less: net income attributable to non-controlling interests (13,969) (5,468) (5,717)
Net income attributable to USPH shareholders $ 34,873 $ 22,256 $ 20,551
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 1.31 $ 1.76 $ 1.64
Shares used in computation - basic and diluted (in shares) 12,666 12,570 12,500
Dividends declared per common share (in dollars per share) $ 0.92 $ 0.80 $ 0.68
Net Patient Revenues [Member]      
Revenues [Abstract]      
Net revenues $ 417,703 $ 389,226 $ 348,839
Other Revenues [Member]      
Revenues [Abstract]      
Net revenues $ 36,208 $ 24,825 $ 7,707